Appraisal of exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015]
NICE has taken the decision to postpone the first appraisal committee meeting for this topic. The committee discussion planned for Tuesday 14 December 2023 will therefore not be taking place.
This delay is necessary to allow the additional time that is needed to ensure the committee has all the evidence needed to inform a full and robust committee discussion leading to the most optimum decision-making.
The technology appraisal will be discussed at a meeting of the Highly Specialised Technologies Evaluation Committee on Wednesday 14 February 2024. Please note that this topic will still be considered as a Single Technology Appraisal.
Coordinator, Corporate Office
National Institute for Health and Care Excellence
2nd Floor 2 Redman Place Gardens | London E20 1JQ | United Kingdom
Web: http://nice.org.uk Meetings held in public: https://www.nice.org.uk/Get-Involved/Meetings-in-public